• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑色素瘤进展和转移过程中异常的蛋白酪氨酸激酶基因表达。

Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis.

作者信息

Easty D J, Herlyn M, Bennett D C

机构信息

St. George's Hospital Medical School, London, UK.

出版信息

Int J Cancer. 1995 Jan 3;60(1):129-36. doi: 10.1002/ijc.2910600119.

DOI:10.1002/ijc.2910600119
PMID:7814145
Abstract

Protein tyrosine kinases have been implicated in tumor initiation and progression. Here we used Northern blotting to study expression of their genes in cultured normal melanocytes and 19 melanoma cell lines from different stages of tumor progression. We detected transcripts for 2 cytoplasmic (ABL and FES) and 6 receptor (ECK, ERB-B2, FGF-R4, IGFI-R, KDR and TIE) kinases but not for receptors RET or TRK-A. Genes for ECK, FGF-R4 and TIE were expressed ectopically in melanomas (not in normal melanocytes). Similarly, ECK protein was detected by immunoblotting in metastatic melanomas but not in normal melanocytes. ECK mRNA levels tended to increase again during late melanoma progression. ECK and TIE mRNAs were also detected in highly metastatic variant cells but not in the corresponding poorly metastatic parental lines. Conversely, FES and KDR gene expression was lost in most advanced primary and metastatic melanomas. These findings suggest positive and negative roles for specific tyrosine kinases during progression.

摘要

蛋白酪氨酸激酶与肿瘤的发生和发展有关。在此,我们运用Northern印迹法研究了它们的基因在培养的正常黑素细胞以及来自肿瘤发展不同阶段的19种黑色素瘤细胞系中的表达情况。我们检测到了2种胞质激酶(ABL和FES)以及6种受体激酶(ECK、ERB - B2、FGF - R4、IGFI - R、KDR和TIE)的转录本,但未检测到受体RET或TRK - A的转录本。ECK、FGF - R4和TIE的基因在黑色素瘤中异位表达(正常黑素细胞中不表达)。同样,通过免疫印迹在转移性黑色素瘤中检测到了ECK蛋白,但在正常黑素细胞中未检测到。在黑色素瘤进展后期,ECK mRNA水平倾向于再次升高。在高转移性变异细胞中也检测到了ECK和TIE mRNA,但在相应的低转移性亲代细胞系中未检测到。相反,在大多数晚期原发性和转移性黑色素瘤中,FES和KDR基因表达缺失。这些发现表明特定酪氨酸激酶在肿瘤进展过程中具有正向和负向作用。

相似文献

1
Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis.黑色素瘤进展和转移过程中异常的蛋白酪氨酸激酶基因表达。
Int J Cancer. 1995 Jan 3;60(1):129-36. doi: 10.1002/ijc.2910600119.
2
Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression.
Cancer Res. 1995 Jun 15;55(12):2528-32.
3
Novel and known protein tyrosine kinases and their abnormal expression in human melanoma.
J Invest Dermatol. 1993 Nov;101(5):679-84. doi: 10.1111/1523-1747.ep12371675.
4
Intertumoral heterogeneity of receptor-tyrosine kinases expression in human melanoma cell lines with different metastatic capabilities.不同转移能力的人黑色素瘤细胞系中受体酪氨酸激酶表达的肿瘤内异质性。
Anticancer Res. 1994 Sep-Oct;14(5A):1759-65.
5
Protein tyrosine kinases in malignant melanoma.
Melanoma Res. 2000 Oct;10(5):401-11. doi: 10.1097/00008390-200010000-00001.
6
Loss of expression of receptor tyrosine kinase family genes PTK7 and SEK in metastatic melanoma.
Int J Cancer. 1997 Jun 11;71(6):1061-5. doi: 10.1002/(sici)1097-0215(19970611)71:6<1061::aid-ijc24>3.0.co;2-f.
7
Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.Lerk-5/Eplg5信使核糖核酸的过表达:人类恶性黑色素瘤中肿瘤发生性增加和转移潜能增强的一种新标志物。
Clin Cancer Res. 1998 Mar;4(3):791-7.
8
Expression of NM23 in human melanoma progression and metastasis.NM23在人类黑色素瘤进展和转移中的表达。
Br J Cancer. 1996 Jul;74(1):109-14. doi: 10.1038/bjc.1996.323.
9
The differential expression of protein kinase C genes in normal human neonatal melanocytes and metastatic melanomas.
Carcinogenesis. 1991 Jan;12(1):105-9. doi: 10.1093/carcin/12.1.105.
10
Enhanced expression of the tie receptor tyrosine kinase mesenger RNA in the vascular endothelium of metastatic melanomas.转移性黑色素瘤血管内皮中酪氨酸激酶受体 Tie 信使核糖核酸的表达增强。
Cancer Res. 1994 Dec 15;54(24):6571-7.

引用本文的文献

1
A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancers.一项评估抗体 DS-8895a 针对 EphA2 在晚期或转移性 EphA2 阳性癌症患者中安全性和生物成像的 1 期临床试验。
Invest New Drugs. 2022 Aug;40(4):747-755. doi: 10.1007/s10637-022-01237-3. Epub 2022 Apr 11.
2
Oncogenic functions and therapeutic targeting of EphA2 in cancer.EphA2 在癌症中的致癌功能和治疗靶点。
Oncogene. 2021 Apr;40(14):2483-2495. doi: 10.1038/s41388-021-01714-8. Epub 2021 Mar 8.
3
Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma.
比较肿瘤基因组学研究确定酪氨酸激酶FES在黑色素瘤中为一种肿瘤抑制因子。
J Clin Invest. 2017 Jun 1;127(6):2310-2325. doi: 10.1172/JCI91291. Epub 2017 May 2.
4
Pleural mesothelial cells in pleural and lung diseases.胸膜和肺部疾病中的胸膜间皮细胞。
J Thorac Dis. 2015 Jun;7(6):964-80. doi: 10.3978/j.issn.2072-1439.2015.02.19.
5
EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia.EphA2是EphA2阳性白血病的治疗靶点,但对正常造血或白血病并非不可或缺。
PLoS One. 2015 Jun 17;10(6):e0130692. doi: 10.1371/journal.pone.0130692. eCollection 2015.
6
Targeted delivery of let-7a microRNA encapsulated ephrin-A1 conjugated liposomal nanoparticles inhibit tumor growth in lung cancer.载 let-7a 微 RNA 的 Ephrin-A1 偶联脂质体纳米粒靶向递释抑制肺癌生长。
Int J Nanomedicine. 2013;8:4481-94. doi: 10.2147/IJN.S41782. Epub 2013 Nov 21.
7
Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?黑素瘤干细胞与转移:模拟造血细胞归巢?
Lab Invest. 2014 Jan;94(1):13-30. doi: 10.1038/labinvest.2013.116. Epub 2013 Oct 14.
8
HER2 as a promising target for cytotoxicity T cells in human melanoma therapy.人黑色素瘤治疗中细胞毒性 T 细胞的 HER2 作为一个有前途的靶点。
PLoS One. 2013 Aug 27;8(8):e73261. doi: 10.1371/journal.pone.0073261. eCollection 2013.
9
Dual-modality micro-positron emission tomography/computed tomography and near-infrared fluorescence imaging of EphB4 in orthotopic glioblastoma xenograft models.EphB4 在同源性脑胶质瘤异种移植模型中的正电子发射断层扫描/计算机断层扫描和近红外荧光成像的双模态研究。
Mol Imaging Biol. 2014 Feb;16(1):74-84. doi: 10.1007/s11307-013-0674-3.
10
The angiogenetic pathway in malignant pleural effusions: Pathogenetic and therapeutic implications.恶性胸腔积液中的血管生成途径:发病机制及治疗意义
Exp Ther Med. 2010 Jan;1(1):3-7. doi: 10.3892/etm_00000001. Epub 2010 Jan 1.